Evaluation of Model-Based Prediction of Pharmacokinetics in the Renal Impairment Population.

about

Evaluation of Model-Based Prediction of Pharmacokinetics in the Renal Impairment Population.

Item

http://www.wikidata.org/entity/Q48114772

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Evaluation of Model-Based Pred ...... e Renal Impairment Population.

@en

Evaluation of Model-Based Pred ...... e Renal Impairment Population.

@nl

type

Item

label

Evaluation of Model-Based Pred ...... e Renal Impairment Population.

@en

Evaluation of Model-Based Pred ...... e Renal Impairment Population.

@nl

prefLabel

Evaluation of Model-Based Pred ...... e Renal Impairment Population.

@en

Evaluation of Model-Based Pred ...... e Renal Impairment Population.

@nl

P1476

Evaluation of Model-Based Pred ...... he Renal Impairment Population

@en

P2093

Jian Lin

http://www.w3.org/2001/XMLSchema#string

Mengyao Li

http://www.w3.org/2001/XMLSchema#string

Ping Zhao

http://www.w3.org/2001/XMLSchema#string

Pravin Jadhav

http://www.w3.org/2001/XMLSchema#string

Tamara Cabalu

http://www.w3.org/2001/XMLSchema#string

Vaishali Sahasrabudhe

http://www.w3.org/2001/XMLSchema#string

P2860

Towards quantitation of the effects of renal impairment and probenecid inhibition on kidney uptake and efflux transporters, using physiologically based pharmacokinetic modelling and simulations

The Simcyp population-based ADME simulator

Combining the 'bottom up' and 'top down' approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical data

Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals

Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir.

Application of a physiologically based pharmacokinetic model informed by a top-down approach for the prediction of pharmacokinetics in chronic kidney disease patients.

Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients

Modeling and predicting drug pharmacokinetics in patients with renal impairment.

Identification and Quantitative Assessment of Uremic Solutes as Inhibitors of Renal Organic Anion Transporters, OAT1 and OAT3.

Pharmacokinetics of cefuroxime in normal and impaired renal function: comparison of high-pressure liquid chromatography and microbiological assays.

P304

364-376

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCPH.1022

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ka Lai Yee

P577

2017-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29077203

http://www.w3.org/2001/XMLSchema#string